Pnc Financial Services Group, Inc. Novartis Ag Transaction History

Pnc Financial Services Group, Inc.

$156 Billion
Q3 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 220,827 shares of NVS stock, worth $21.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

220,827

Previous 223,037 0.99%

Holding current value

$21.4 Million

Previous $23.7 Million 6.97%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$106.13 - $120.89 $234,547 - $267,166	-2,210 Reduced 0.99%	220,827 $25.4 Million
Q2 2024 Aug 09, 2024	SELL	$92.57 - $107.37 $1.18 Million - $1.37 Million	-12,740 Reduced 5.4%	223,037 $23.7 Million
Q1 2024 May 10, 2024	SELL	$95.27 - $108.47 $858,287 - $977,206	-9,009 Reduced 3.68%	235,777 $22.8 Million
Q4 2023 Feb 09, 2024	SELL	$92.27 - $101.54 $4.67 Million - $5.14 Million	-50,653 Reduced 17.14%	244,786 $24.7 Million
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $1.11 Million - $1.23 Million	-11,720 Reduced 3.82%	295,439 $30.1 Million
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $373,040 - $422,997	-4,032 Reduced 1.3%	307,159 $31 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $947,555 - $1.1 Million	-11,840 Reduced 3.67%	311,191 $28.6 Million
Q4 2022 Feb 10, 2023	SELL	$75.55 - $92.52 $2.4 Million - $2.93 Million	-31,705 Reduced 8.94%	323,031 $29.3 Million
Q3 2022 Nov 10, 2022	BUY	$74.61 - $87.26 $163,619 - $191,361	2,193 Added 0.62%	354,736 $27 Million
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $1.14 Million - $1.32 Million	-14,110 Reduced 3.85%	352,543 $29.8 Million
Q1 2022 May 12, 2022	SELL	$80.11 - $90.62 $1.74 Million - $1.97 Million	-21,691 Reduced 5.59%	366,653 $32.2 Million
Q4 2021 Feb 11, 2022	BUY	$79.7 - $88.13 $4.36 Million - $4.82 Million	54,679 Added 16.39%	388,344 $34 Million
Q3 2021 Nov 05, 2021	SELL	$81.78 - $95.14 $337,506 - $392,642	-4,127 Reduced 1.22%	333,665 $27.3 Million
Q2 2021 Aug 06, 2021	SELL	$85.24 - $94.15 $794,181 - $877,195	-9,317 Reduced 2.68%	337,792 $30.8 Million
Q1 2021 May 07, 2021	SELL	$83.5 - $98.47 $115,063 - $135,691	-1,378 Reduced 0.4%	347,109 $29.7 Million
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $1.41 Million - $1.7 Million	-18,018 Reduced 4.92%	348,487 $32.9 Million
Q3 2020 Nov 06, 2020	SELL	$82.14 - $91.0 $651,780 - $722,085	-7,935 Reduced 2.12%	366,505 $31.9 Million
Q2 2020 Aug 07, 2020	SELL	$80.93 - $91.1 $1.26 Million - $1.42 Million	-15,624 Reduced 4.01%	374,440 $32.7 Million
Q1 2020 May 08, 2020	SELL	$70.67 - $99.01 $256,037 - $358,713	-3,623 Reduced 0.92%	390,064 $32.2 Million
Q4 2019 Feb 07, 2020	SELL	$84.35 - $95.37 $595,595 - $673,407	-7,061 Reduced 1.76%	393,687 $37.3 Million
Q3 2019 Nov 08, 2019	SELL	$85.54 - $94.26 $351,312 - $387,125	-4,107 Reduced 1.01%	400,748 $34.8 Million
Q2 2019 Aug 09, 2019	SELL	$75.4 - $92.8 $304,239 - $374,448	-4,035 Reduced 0.99%	404,855 $0
Q1 2019 May 10, 2019	SELL	$75.32 - $86.15 $791,537 - $905,350	-10,509 Reduced 2.51%	408,890 $0
Q4 2018 Feb 08, 2019	SELL	$73.66 - $82.02 $511,347 - $569,382	-6,942 Reduced 1.63%	419,399 $32.2 Million
Q3 2018 Nov 09, 2018	SELL	$66.94 - $77.43 $476,612 - $551,301	-7,120 Reduced 1.64%	426,341 $0
Q2 2018 Aug 10, 2018	SELL	$64.91 - $73.36 $457,875 - $517,481	-7,054 Reduced 1.6%	433,461 $0
Q1 2018 May 11, 2018	SELL	$70.39 - $84.15 $1.21 Million - $1.44 Million	-17,168 Reduced 3.75%	440,515 $0
Q4 2017 Feb 09, 2018	SELL	$72.33 - $77.64 $533,506 - $572,672	-7,376 Reduced 1.59%	457,683 $0
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $34.5 Million - $35.9 Million	465,059	465,059 $0

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Novartis Ag Transaction History